Long-Term Efficacy of Triple Oral Therapy for Type 2 Diabetes Mellitus
- 1 July 2002
- journal article
- Published by Elsevier in Endocrine Practice
- Vol. 8 (4) , 271-275
- https://doi.org/10.4158/ep.8.4.271
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical evidence of thiazolidinedione‐induced improvement of pancreatic β‐cell function in patients with type 2 diabetes mellitusDiabetes, Obesity and Metabolism, 2002
- Conversion From Troglitazone To RosiglitazoneEndocrine Practice, 2001
- β-Cell Mass Dynamics in Zucker Diabetic Fatty RatsDiabetes, 2001
- Is Avoiding Insulin Therapy an Achievable and Worthwhile Goal?Endocrine Practice, 2000
- Pharmacologic Therapy for Type 2 Diabetes MellitusAnnals of Internal Medicine, 1999
- Improved Glycemic Control with use of oral Hypoglycemic Therapy with or Without InsulinEndocrine Practice, 1998
- Outcome of Metformin-Facilitated Reinitiation of Oral Diabetic Therapy in Insulin-Treated Patients with Non-Insulin-Dependent Diabetes MellitusEndocrine Practice, 1997
- Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Pancreatic β-Cells in ObesityJournal of Biological Chemistry, 1995
- Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.Proceedings of the National Academy of Sciences, 1994